Avecho Biotechnology Limited (FRA:OEZ)
Germany
· Delayed Price · Currency is EUR 0.0040
-0.0010 (-20.00%)
At close: Dec 5, 2025
Avecho Biotechnology Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1.38 | 1.13 | 0.47 | 1.13 | 0.79 | 0.38 | Upgrade
|
| Revenue Growth (YoY) | 306.88% | 139.19% | -58.06% | 42.30% | 106.33% | -90.92% | Upgrade
|
| Cost of Revenue | 0.52 | 0.46 | 0.52 | 0.34 | 0.29 | 0.14 | Upgrade
|
| Gross Profit | 0.86 | 0.67 | -0.04 | 0.79 | 0.51 | 0.24 | Upgrade
|
| Selling, General & Admin | 2.58 | 2.04 | 2.43 | 2.26 | 2.92 | 2.81 | Upgrade
|
| Research & Development | 1.78 | 1.7 | 0.95 | 0.87 | 0.99 | 0.24 | Upgrade
|
| Operating Expenses | 4.36 | 3.74 | 3.38 | 3.13 | 3.91 | 3.05 | Upgrade
|
| Operating Income | -3.5 | -3.06 | -3.42 | -2.34 | -3.41 | -2.81 | Upgrade
|
| Interest Expense | -0.12 | -0.06 | -0.02 | -0.01 | -0.01 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -3.62 | -3.12 | -3.44 | -2.34 | -3.42 | -2.82 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.18 | Upgrade
|
| Pretax Income | -3.62 | -3.12 | -3.44 | -2.34 | -3.42 | -2.63 | Upgrade
|
| Earnings From Continuing Operations | -3.62 | -3.12 | -3.44 | -2.34 | -3.42 | -2.63 | Upgrade
|
| Net Income | -3.62 | -3.12 | -3.44 | -2.34 | -3.42 | -2.63 | Upgrade
|
| Net Income to Common | -3.62 | -3.12 | -3.44 | -2.34 | -3.42 | -2.63 | Upgrade
|
| Shares Outstanding (Basic) | 3,170 | 3,169 | 2,268 | 1,838 | 1,802 | 1,591 | Upgrade
|
| Shares Outstanding (Diluted) | 3,170 | 3,169 | 2,268 | 1,838 | 1,802 | 1,591 | Upgrade
|
| Shares Change (YoY) | 9.80% | 39.73% | 23.41% | 1.97% | 13.27% | 0.86% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | 1.19 | -3.97 | -3.18 | -1.72 | -3.3 | -1.43 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Gross Margin | 62.27% | 59.32% | -9.25% | 70.23% | 64.00% | 62.63% | Upgrade
|
| Operating Margin | -253.71% | -270.59% | -722.46% | -206.86% | -429.20% | -731.42% | Upgrade
|
| Profit Margin | -262.41% | -275.64% | -725.70% | -207.43% | -430.46% | -685.04% | Upgrade
|
| Free Cash Flow Margin | 86.31% | -350.38% | -671.51% | -152.16% | -416.01% | -371.56% | Upgrade
|
| EBITDA | -3.36 | -2.92 | -3.24 | -2.11 | -2.98 | -2.28 | Upgrade
|
| EBITDA Margin | -243.67% | -257.80% | - | -186.47% | - | - | Upgrade
|
| D&A For EBITDA | 0.14 | 0.14 | 0.18 | 0.23 | 0.43 | 0.54 | Upgrade
|
| EBIT | -3.5 | -3.06 | -3.42 | -2.34 | -3.41 | -2.81 | Upgrade
|
| EBIT Margin | -253.71% | -270.59% | - | -206.86% | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.